EpiSante Biomedical Co., Ltd. has been officially approved through the review process and has joined the Hsinchu Biomedical Science Park as a member. The Hsinchu Biomedical Science Park, adjacent to the Hsinchu High-Speed Rail Station in Zhubei City, spans 38.1 hectares and is dedicated to the incubation and development of advanced medical device and new drug research and development.

EpiSante Biomedical will conduct cutting-edge biomedical research here, continue to complete clinical trials with medical centers, and strive to develop a new generation of detection technologies to provide viable and effective medical solutions. This represents a significant milestone in our commitment to ongoing innovation and growth in the biomedical field. We are excited about the prospect of collaborating with other leading companies and research institutions in the world to collectively advance the biomedical industry.